140 related articles for article (PubMed ID: 35980802)
41. METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition.
Zhu Y; Peng X; Zhou Q; Tan L; Zhang C; Lin S; Long M
Cell Death Dis; 2022 Apr; 13(4):358. PubMed ID: 35436987
[TBL] [Abstract][Full Text] [Related]
42. Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy.
Chen K; Feng L; Hu W; Chen J; Wang X; Wang L; He Y
FASEB J; 2019 Mar; 33(3):4571-4585. PubMed ID: 30571313
[TBL] [Abstract][Full Text] [Related]
43. Mettl3 promotes oxLDL-mediated inflammation through activating STAT1 signaling.
Li Z; Xu Q; Huangfu N; Chen X; Zhu J
J Clin Lab Anal; 2022 Jan; 36(1):e24019. PubMed ID: 34825733
[TBL] [Abstract][Full Text] [Related]
44. PINK1-mediated mitophagy maintains pluripotency through optineurin.
Wang C; Liu K; Cao J; Wang L; Zhao Q; Li Z; Zhang H; Chen Q; Zhao T
Cell Prolif; 2021 May; 54(5):e13034. PubMed ID: 33931895
[TBL] [Abstract][Full Text] [Related]
45. METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis.
Pan J; Liu F; Xiao X; Xu R; Dai L; Zhu M; Xu H; Xu Y; Zhao A; Zhou W; Dang Y; Ji G
J Exp Clin Cancer Res; 2022 Jan; 41(1):19. PubMed ID: 35012593
[TBL] [Abstract][Full Text] [Related]
46. Methyltransferase-like 3 (METTL3) mediated N6-methyladenosine (m6A) modifications facilitate mir-25-3p maturation to promote gastrointestinal stromal tumors (GISTs) progression.
Qian K; Xu W; Xia X; Ding J
Genes Genomics; 2022 Dec; 44(12):1519-1530. PubMed ID: 36040683
[TBL] [Abstract][Full Text] [Related]
47. METTL3 counteracts premature aging via m6A-dependent stabilization of MIS12 mRNA.
Wu Z; Shi Y; Lu M; Song M; Yu Z; Wang J; Wang S; Ren J; Yang YG; Liu GH; Zhang W; Ci W; Qu J
Nucleic Acids Res; 2020 Nov; 48(19):11083-11096. PubMed ID: 33035345
[TBL] [Abstract][Full Text] [Related]
48. METTL3-mediated m6A modification is required for cerebellar development.
Wang CX; Cui GS; Liu X; Xu K; Wang M; Zhang XX; Jiang LY; Li A; Yang Y; Lai WY; Sun BF; Jiang GB; Wang HL; Tong WM; Li W; Wang XJ; Yang YG; Zhou Q
PLoS Biol; 2018 Jun; 16(6):e2004880. PubMed ID: 29879109
[TBL] [Abstract][Full Text] [Related]
49. METTL3 promotes colorectal cancer metastasis by stabilizing PLAU mRNA in an m6A-dependent manner.
Yu T; Liu J; Wang Y; Chen W; Liu Z; Zhu L; Zhu W
Biochem Biophys Res Commun; 2022 Jul; 614():9-16. PubMed ID: 35567945
[TBL] [Abstract][Full Text] [Related]
50. Discovery of Small Molecules that Activate RNA Methylation through Cooperative Binding to the METTL3-14-WTAP Complex Active Site.
Selberg S; Blokhina D; Aatonen M; Koivisto P; Siltanen A; Mervaala E; Kankuri E; Karelson M
Cell Rep; 2019 Mar; 26(13):3762-3771.e5. PubMed ID: 30917327
[TBL] [Abstract][Full Text] [Related]
51. Optineurin-mediated mitophagy protects renal tubular epithelial cells against accelerated senescence in diabetic nephropathy.
Chen K; Dai H; Yuan J; Chen J; Lin L; Zhang W; Wang L; Zhang J; Li K; He Y
Cell Death Dis; 2018 Jan; 9(2):105. PubMed ID: 29367621
[TBL] [Abstract][Full Text] [Related]
52. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C
J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
[TBL] [Abstract][Full Text] [Related]
53. Suppression of optineurin impairs the progression of hepatocellular carcinoma through regulating mitophagy.
Inokuchi S; Yoshizumi T; Toshima T; Itoh S; Yugawa K; Harada N; Mori H; Fukuhara T; Matsuura Y; Mori M
Cancer Med; 2021 Mar; 10(5):1501-1514. PubMed ID: 33600074
[TBL] [Abstract][Full Text] [Related]
54. SUMOylation of the m6A-RNA methyltransferase METTL3 modulates its function.
Du Y; Hou G; Zhang H; Dou J; He J; Guo Y; Li L; Chen R; Wang Y; Deng R; Huang J; Jiang B; Xu M; Cheng J; Chen GQ; Zhao X; Yu J
Nucleic Acids Res; 2018 Jun; 46(10):5195-5208. PubMed ID: 29506078
[TBL] [Abstract][Full Text] [Related]
55. METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway.
Ye K; Li L; Wu B; Wang D
Genes Genomics; 2022 Nov; 44(11):1311-1322. PubMed ID: 36074324
[TBL] [Abstract][Full Text] [Related]
56. Hepatitis B Virus X Protein Expression Is Tightly Regulated by N6-Methyladenosine Modification of Its mRNA.
Kim GW; Siddiqui A
J Virol; 2022 Feb; 96(4):e0165521. PubMed ID: 34851655
[TBL] [Abstract][Full Text] [Related]
57. METTL3-mediated m6A mRNA contributes to the resistance of carbon-ion radiotherapy in non-small-cell lung cancer.
Xu X; Zhang P; Huang Y; Shi W; Mao J; Ma N; Kong L; Guo L; Liu J; Chen J; Lu R
Cancer Sci; 2023 Jan; 114(1):105-114. PubMed ID: 36114749
[TBL] [Abstract][Full Text] [Related]
58. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.
Wang X; Lu X; Wang P; Chen Q; Xiong L; Tang M; Hong C; Lin X; Shi K; Liang L; Lin J
J Transl Med; 2022 May; 20(1):198. PubMed ID: 35509101
[TBL] [Abstract][Full Text] [Related]
59. METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma.
Zhang Z; Fu J; Zhang Y; Qin X; Wang Y; Xing C
BMC Gastroenterol; 2023 Jun; 23(1):217. PubMed ID: 37344779
[TBL] [Abstract][Full Text] [Related]
60. m6A methylated EphA2 and VEGFA through IGF2BP2/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K/AKT and ERK1/2 signaling.
Liu X; He H; Zhang F; Hu X; Bi F; Li K; Yu H; Zhao Y; Teng X; Li J; Wang L; Zhang Y; Wu Q
Cell Death Dis; 2022 May; 13(5):483. PubMed ID: 35595748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
